Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.1.8 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.39.3 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BQ.1.8.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.75.3 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CY.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FR.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBJ.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CP.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GJ.1.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.56.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.21EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.13.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CK.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.1.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.11.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDLEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.29.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.29.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.10.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.10.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.56EHuang-EGCAGCAGTACGCACACAATC20552637626357R-7148.11China
BA.2.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.75.3 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.35ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CY.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FR.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBJ.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CP.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GJ.1.2.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.1.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.56.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.21ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.13.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CK.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.1.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.11.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDLECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used